Stocks · News reference
Axcelis Technologies Announces Plans To Invest $35M In New Ion Implantation Equipment Manufacturing Facility In Pyeongtaek, Korea; Groundbreaking Set For October 20, Production To Begin H2 2028
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Axcelis Technologies Reports Q2 2026 Results: Full Earnings Call Transcript
Axcelis Technologies (NASDAQ:ACLS) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you by
Shares of semiconductor and chip companies are trading higher amid broader technology sector gains after Broadcom's plans to finance up to $60 billion to provide chips for Anthropic. Also, reports suggesting Samsung may raise HBM prices threefold in 2027 underpins demand and pricing power confidence across the sector.
KLIC Up 93.6% in a Year: Should Investors Bet on the Stock Now?
Kulicke & Soffa Industries (KLIC) has surged 93.6% over the past year, driven by AI-led semiconductor demand and advanced packaging solutions. The company reported Q3 fiscal 2026 revenues of $330.4M (up 122.6% YoY) and non-GAAP EPS of $1.20. KLIC expects fiscal 2026 TCB revenues above $100M and is building $400M in annual TCB capacity. Management projects Q4 revenues around $375M with non-GAAP EPS of $1.42, supported by strong order visibility and expanding AI infrastructure opportunities.